Tags

Type your tag names separated by a space and hit enter

The selective role of endoscopic sclerotherapy in the management of bleeding esophageal varices.
Am Surg. 1986 Nov; 52(11):573-6.AS

Abstract

Twenty-one patients (62% Child's C) underwent endoscopic sclerotherapy (ES) to control hemorrhage from esophageal varices. Four patients exsanguinated; bleeding was controlled in the remaining 17 patients (81%). Of this latter group, 14 patients were discharged from the hospital and three patients died from causes other than hemorrhage. A protocol of continued ES was offered to those patients with estimated poor hepatic reserve and to those with excellent reserve who refused portasystemic shunt procedures. During a mean 13 month follow-up of the six patients in this group, rebleeding occurred in two patients (one of whom died). All three patients with excellent hepatic reserve who underwent elective portacaval shunt have suffered neither morbidity nor further hemorrhagic episodes. No significant morbidity related to ES was encountered. ES is recommended in the acute phase of managing all patients with unremittent variceal hemorrhage, and on a continued basis for those with poor hepatic reserve. Patients with excellent reserve should be offered elective portasystemic shunt, accepting the risk of surgical intervention as fair trade-off for its superiority over ES in controlling hemorrhage.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

3490812

Citation

Thomas, T, and J J. Ferrara. "The Selective Role of Endoscopic Sclerotherapy in the Management of Bleeding Esophageal Varices." The American Surgeon, vol. 52, no. 11, 1986, pp. 573-6.
Thomas T, Ferrara JJ. The selective role of endoscopic sclerotherapy in the management of bleeding esophageal varices. Am Surg. 1986;52(11):573-6.
Thomas, T., & Ferrara, J. J. (1986). The selective role of endoscopic sclerotherapy in the management of bleeding esophageal varices. The American Surgeon, 52(11), 573-6.
Thomas T, Ferrara JJ. The Selective Role of Endoscopic Sclerotherapy in the Management of Bleeding Esophageal Varices. Am Surg. 1986;52(11):573-6. PubMed PMID: 3490812.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The selective role of endoscopic sclerotherapy in the management of bleeding esophageal varices. AU - Thomas,T, AU - Ferrara,J J, PY - 1986/11/1/pubmed PY - 1986/11/1/medline PY - 1986/11/1/entrez SP - 573 EP - 6 JF - The American surgeon JO - Am Surg VL - 52 IS - 11 N2 - Twenty-one patients (62% Child's C) underwent endoscopic sclerotherapy (ES) to control hemorrhage from esophageal varices. Four patients exsanguinated; bleeding was controlled in the remaining 17 patients (81%). Of this latter group, 14 patients were discharged from the hospital and three patients died from causes other than hemorrhage. A protocol of continued ES was offered to those patients with estimated poor hepatic reserve and to those with excellent reserve who refused portasystemic shunt procedures. During a mean 13 month follow-up of the six patients in this group, rebleeding occurred in two patients (one of whom died). All three patients with excellent hepatic reserve who underwent elective portacaval shunt have suffered neither morbidity nor further hemorrhagic episodes. No significant morbidity related to ES was encountered. ES is recommended in the acute phase of managing all patients with unremittent variceal hemorrhage, and on a continued basis for those with poor hepatic reserve. Patients with excellent reserve should be offered elective portasystemic shunt, accepting the risk of surgical intervention as fair trade-off for its superiority over ES in controlling hemorrhage. SN - 0003-1348 UR - https://www.unboundmedicine.com/medline/citation/3490812/The_selective_role_of_endoscopic_sclerotherapy_in_the_management_of_bleeding_esophageal_varices_ L2 - https://www.diseaseinfosearch.org/result/2658 DB - PRIME DP - Unbound Medicine ER -